Peter H. Sayre
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter H. Sayre.
Immunological Reviews | 1989
Philippe Moingeon; Hsiu-Ching Chang; Peter H. Sayre; Linda K. Clayton; Andres Alcover; Phyllis Gardner; Ellis L. Reinherz
The CD2 molecule is a 50-55KD transmembrane glycoprotein expressed on the vast majority of thymocytes and virtually all peripheral T lymphocytes. Its functions are two-fold: adhesion and activation. CD2 serves to facilitate conjugate formation between the T-lineage cell and its cognate partner via intermolecular interaction of CD2 and LFA-3 on the former and latter cells, respectively. Perturbation of the CD2 extracellular segment by certain combinations of anti-CD2 MAbs or LFA-3 and a single anti-CD2 MAb activate T-lineage function. These CD2-mediated activation events also synergize with signals mediated through the TCR to augment T-cell response. Based on microchemical analysis of immunoaffinity-purified human CD2 and cDNA and genomic cloning of mouse and human molecules, considerable structural information is now available. The mature surface human CD2 molecule consists of 327 amino acids: a 185 aa extracellular segment; a 25 aa hydrophobic transmembrane segment; and a 117 aa cytoplasmic domain rich in prolines and basic residues. The CD2 gene is comprised of five exons which span approximately 12 Kb on chromosome 1. A similar protein structure and gene exon organization is found for the mouse CD2 homologue. The CD2 adhesion domain is approximately 103 aa in length and is encoded by a single exon (exon 2). This domain is resistant to proteolysis, even though it lacks any intrachain disulfides and, like the entire extracellular segment protein expressed in a baculovirus system, binds to its cellular ligand, LFA-3. The latter occurs with a micromolar Kd. This relatively low affinity suggests that multivalent interactions among CD2 monomers on the T cells and individual LFA-3 structures on the cognate partner are important in enhancing the avidity of the T-cell interaction with its target or stimulator cell. The affinity of the CD2 extracellular segment for LFA-3 is not affected by truncations in the CD2 cytoplasmic domain, implying that ligand binding is not regulated by intracellular mechanisms. Given that CD2 mRNA expression and surface CD2 copy number are increased by more than one order of magnitude post-TCR stimulation, it is more likely that adhesion via CD2 is modulated by alteration in surface copy number. Analysis of early transduction events occurring via CD3-Ti (TCR) and CD2 including single channel Ca2+ patch-clamp recordings on living human T lymphocytes indicate a virtual identity of signals.(ABSTRACT TRUNCATED AT 400 WORDS)
Scandinavian Journal of Rheumatology | 1988
Peter H. Sayre; Ellis L. Reinherz
The human CD2 molecule is a 50kd surface glycoprotein expressed on greater than 95% of thymocytes and all peripheral T lymphocytes which mediates both adhesion between T cells and their targets, and subsequent T cell activation events. Molecular cloning of human CD2 cDNAs predicts a mature CD2 protein of 327 amino acids, with an extracellular segment of 185 amino acids, a transmembrane domain of 24 amino acids and an intracytoplasmic region of 117 amino acids. Genomic cloning shows that the extracellular segment is encoded by two exons, the transmembrane segment by a single exon and the intracytoplasmic region by a single exon. Expression and biochemical analysis of a soluble extracellular domain CD2 molecule reveal that it expresses native CD2 epitopes and contains a stable 15kd NH2-terminal fragment corresponding to a single exon. Binding analyses of the soluble CD2 molecule indicate that it binds specifically to a known cell-surface ligand for CD2 at a relatively low affinity, thus suggesting that T cell-target adhesion mediated by CD2 and its ligand depends on multimeric attachment between an array of CD2 molecules and their cognate ligands.
Proceedings of the National Academy of Sciences of the United States of America | 1988
Margaret A. Shipp; Neil E. Richardson; Peter H. Sayre; Nicholas R. Brown; E L Masteller; Linda K. Clayton; Jerome Ritz; Ellis L. Reinherz
Archive | 1989
Ellis L. Reinherz; Peter H. Sayre; Rebecca E. Hussey; Hsiu-Ching Chang
Journal of Experimental Medicine | 1989
Peter H. Sayre; Rebecca E. Hussey; Hsiu-Ching Chang; T. L. Ciardelli; Ellis L. Reinherz
Proceedings of the National Academy of Sciences of the United States of America | 1987
Peter H. Sayre; Hsiu-Ching Chang; Rebecca E. Hussey; Nicholas R. Brown; Neil E. Richardson; Giulio Spagnoli; Linda K. Clayton; Ellis L. Reinherz
Journal of Biological Chemistry | 1990
Michael A. Recny; E A Neidhardt; Peter H. Sayre; T. L. Ciardelli; Ellis L. Reinherz
Proceedings of the National Academy of Sciences of the United States of America | 1988
Neil E. Richardson; Hsiu-Ching Chang; Nicholas R. Brown; Rebecca E. Hussey; Peter H. Sayre; Ellis L. Reinherz
The Open Arthritis Journal | 2011
U. Specks; Peter A. Merkel; Gs Hoffman; Carol A. Langford; Robert Spiera; Phil Seo; Cees G M Kallenberg; E. William St. Clair; Linna Ding; Lisa Webber; Masoud Mokhtarani; Nadia K. Tchao; Peter H. Sayre; Vicky Seyfert-Margolis; David Ikle; Paul P. Brunetta; David Yu Zhang; Lourdes P. Sejismundo; Mark Mueller; John H. Stone
Proceedings of the National Academy of Sciences of the United States of America | 1988
Don J. Diamond; Linda K. Clayton; Peter H. Sayre; Ellis L. Reinherz